SCHEMBL9984770

SCHEMBL9984770

CS(=O)(=O)OCCN(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 3/20 0.44
MTNR1A P48039 4/20 0.42
MTNR1B P49286 4/20 0.42
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MMP9 P14780 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
CA12 O43570 1/20 0.37
SIGMAR1 Q99720 1/20 0.36
KCNH2 Q12809 2/20 0.36
NR3C1 P04150 1/20 0.36
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8470751 0.86 NR3C2 (0.38) NR3C2MTNR1AMTNR1BKDM4EUSP2
SCHEMBL2401899 0.84 CA12 (0.47) NR3C2MTNR1AMTNR1BKDM4EUSP2
SCHEMBL13338130 0.78 EGFR (0.48) NR3C2KDM4EUSP2ALDH1A1LMNA
SCHEMBL5672847 0.76 MCHR1 (0.45) NR3C2ALDH1A1TSHRCA2CA9
SCHEMBL14421026 0.76 TSHR (0.36) NR3C2KDM4EUSP2ALDH1A1LMNA
SCHEMBL5746057 0.75 SMN1; SMN2 (0.55) ALDH1A1LMNATSHRSIGMAR1
SCHEMBL25335390 0.74 MEN1 (0.46) MTNR1AMTNR1BALDH1A1LMNAPPARG
SCHEMBL8290870 0.74 KCNN4 (0.38) NR3C2KDM4EUSP2ALDH1A1LMNA
SCHEMBL4499222 0.74 SMN1; SMN2 (0.51) ALDH1A1LMNATSHRCA2
SCHEMBL28643624 0.73 F2 (0.52) ALDH1A1TSHRCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9205156-B2 Molecular imaging agents HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED (IL) 2015-12-08 US disclosed
US-20110293519-A1 MOLECULAR IMAGING AGENTS HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED (IL) 2011-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110293519-A1 MOLECULAR IMAGING AGENTS TNNI3, FABP3, TNNT2 NR3C2 4485/4885MTNR1A 1911/4885MTNR1B 1650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.